🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to (1) compare the efficacy of the BEACOPP regimen w...
Status
Completed
Location
Multiple Locations
Start Date
1998-05
Trial ID
NCT00264953
The current standard treatment for advanced Hodgkin's lymphoma 6-8 cycles o...
Status
Completed
Location
Department of Medical Oncology, Cancer Institute (WIA), Adyar
Start Date
2011-01
Trial ID
NCT01304849
Treatments Being Tested
The FIL-Rouge is a randomized, open-label, multicenter, phase III, 2-arm st...
Status
Completed
Location
I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1
Start Date
2017-08-01
Trial ID
NCT03159897
Treatments Being Tested
Primary objective of the trial is to demonstrate non-inferior efficacy of s...
Status
Unknown
Location
University Hospital of Cologne
Start Date
2016-07
Trial ID
NCT02661503
Early interim-PET after two courses of chemotherapy is a powerful outcome p...
Status
Unknown
Location
Azienda Ospedaliera Santa Croce e Carle
Start Date
2006-01
Trial ID
NCT00877747
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Active Not Recruiting
Location
Sint Augustinus Ziekenhuis
Start Date
1998-10
Trial ID
NCT00005584
Hodgkin's Lymphoma (HL) is a neoplasm that affects the lymph nodes and the ...
Status
Unknown
Location
Hospital Civil de Guadalajara Fray Antonio Alcalde
Start Date
2022-07-11
Trial ID
NCT05490953
Treatments Being Tested
This study is designed to test: 1. in patients with negative positron-emis...
Status
Completed
Location
1st Dept. of Medicine, Cologne University Hospital
Start Date
2008-05
Trial ID
NCT00515554
Treatments Being Tested
The Purpose of this trial is: * to determine complete response rate (CRR) ...
Status
Completed
Location
1st Dept. of Medicine, Cologne University Hospital
Start Date
2012-10
Trial ID
NCT01569204
The choice of a preferred first-line treatment requires balancing the desir...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale di Tumori di Milano
Start Date
2000-03
Trial ID
NCT01251107